Website Information
    Web Site Information :.   Site Info    Whois    Traceroute    RBL Check  

Enter Web Site URL Address:
 

cevimeline.biz: Sjögren's Syndrome Dry-Mouth Treatment | EVOXAC® (cevimeline HCl)
Learn about EVOXAC® (cevimeline HCl).  
 
 

Sjögren's Syndrome Dry-Mouth Treatment | EVOXAC® (cevimeline HCl)

Description: Learn about EVOXAC® (cevimeline HCl).

Keywords: EVOXAC, dry-mouth treatment, Sjögren’s syndrome treatment

Tags: cevimeline, home, mouth, dry, treatment, syndrome, sjögren, hcl, evoxac®, evoxac, questions, doctor, information, tips, learn, coping, dcsimg, safety, important, daiichi, sankyo, product, healthcare, provider, www, tell, effects, fda, use, html, click, dsi, patientassistance, com, medwatch, facts, news, privacy, possible, policy,

Cevimeline.biz

Content Revalency: Title: 80.00%   Description: 60.00%   Keywords: 85.71%  |  Document size: 12,531 bytes
More info: Whois - Trace Route - RBL Check
 
CEVIMELINE.BIZ - Site Location
Country/Flag US United States
City/Region/Zip Code Sparta, NJ, 07871
Organization Sankyo Pharma
Internet Service Provider Sprint
 
CEVIMELINE.BIZ - Domain Information
Domain CEVIMELINE.BIZ   [ Traceroute  RBL/DNSBL lookup ]
Registrar GODADDY.COM, INC.
Whois server whois.biz
Created 14-Feb-2009
Updated 12-Aug-2016
Expires 13-Feb-2020
Time Left 0 days 0 hours 0 minutes
Status clientDeleteProhibited clientRenewProhibited clientTransferProhibited clientUpdateProhibited
DNS servers NS51.DOMAINCONTROL.COM   208.109.14.47
NS52.DOMAINCONTROL.COM   208.109.255.26
 
CEVIMELINE.BIZ - DNS Information
IP Address 205.243.75.174 ~ Whois - Trace Route - RBL Check
Domain Name Servers ns51.domaincontrol.com   97.74.105.26
ns52.domaincontrol.com   173.201.73.26
Mail Exchange smtp.secureserver.net   92.204.80.0
mailstore1.secureserver.net   92.204.80.3
 
Site Response Header
Response HTTP/1.1 301 Moved Permanently
Server Sun-Java-System-Web-Server/7.0
Date Sat, 09 Apr 2011 23:31:40 GMT
Content-Type text/html


  IP Index    TLD Index    Domain Index    Site Index New   Copyright © 2024 Cybernet Quest.